Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
GE HealthCare Technologies Inc (NASDAQ: GEHC) closed the day trading at $71.32 down -0.45% from the previous closing price of $71.64. In other words, the price has decreased by -$0.45 from its previous closing price. On the day, 6.26 million shares were traded. GEHC stock price reached its highest trading level at $73.01 during the session, while it also had its lowest trading level at $71.11.
Ratios:
For a better understanding of GEHC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.87. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.88.
On March 11, 2025, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $85 to $100.
Jefferies Upgraded its Hold to Buy on January 08, 2025, whereas the target price for the stock was revised from $95 to $103.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 18 ’25 when Newcomb George A. sold 2,000 shares for $92.54 per share. The transaction valued at 185,080 led to the insider holds 7,462 shares of the business.
Rott Roland sold 3,577 shares of GEHC for $309,339 on Nov 06 ’24. The CEO, Imaging now owns 24,298 shares after completing the transaction at $86.48 per share. On Nov 06 ’24, another insider, Roland Rott, who serves as the Officer of the company, bought 3,577 shares for $86.48 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 32561999872 and an Enterprise Value of 39315005440. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.60, and their Forward P/E ratio for the next fiscal year is 14.63. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.64 while its Price-to-Book (P/B) ratio in mrq is 3.35. Its current Enterprise Value per Revenue stands at 1.969 whereas that against EBITDA is 10.546.
Stock Price History:
The Beta on a monthly basis for GEHC is 1.28, which has changed by -0.14525408 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, GEHC has reached a high of $94.80, while it has fallen to a 52-week low of $57.65. The 50-Day Moving Average of the stock is -2.91%, while the 200-Day Moving Average is calculated to be -10.00%.
Shares Statistics:
Over the past 3-months, GEHC traded about 4.07M shares per day on average, while over the past 10 days, GEHC traded about 4763400 shares per day. A total of 457.88M shares are outstanding, with a floating share count of 456.62M. Insiders hold about 0.28% of the company’s shares, while institutions hold 77.33% stake in the company. Shares short for GEHC as of 1752537600 were 6615274 with a Short Ratio of 1.62, compared to 1749772800 on 6388439. Therefore, it implies a Short% of Shares Outstanding of 6615274 and a Short% of Float of 1.91.
Earnings Estimates
Current recommendations for the stock of the company come from 14.0 analysts. The consensus estimate for the next quarter is $1.39, with high estimates of $1.43 and low estimates of $1.34.
Analysts are recommending an EPS of between $4.55 and $4.26 for the fiscal current year, implying an average EPS of $4.51. EPS for the following year is $4.83, with 19.0 analysts recommending between $5.13 and $4.05.
Revenue Estimates
13 analysts predict $5.07B in revenue for the current quarter. It ranges from a high estimate of $5.11B to a low estimate of $5.01B. As of the current estimate, GE HealthCare Technologies Inc’s year-ago sales were $4.86BFor the next quarter, 13 analysts are estimating revenue of $5.61B. There is a high estimate of $5.68B for the next quarter, whereas the lowest estimate is $5.53B.
A total of 19 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.58B, while the lowest revenue estimate was $20.08B, resulting in an average revenue estimate of $20.4B. In the same quarter a year ago, actual revenue was $19.67BBased on 19 analysts’ estimates, the company’s revenue will be $21.34B in the next fiscal year. The high estimate is $21.71B and the low estimate is $20.78B.
